Physician profile
Perry E Edinger
NPI 1003169236
$423.45
in general payments reported to CMS, 2019-2025
10 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $264 · 2024: $52.82 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rti Surgical, INC | $181.31 | 2023 | |
| Vericel Corporation | $56.82 | 2025 | Maci |
| Orthofix Medical, INC. | $31.61 | 2025 | Physio-Stim |
| Nalu Medical, INC. | $31.46 | 2024 | Nalu Neurostimulation System |
| Ethicon US, LLC | $26.67 | 2023 | Stratafix |
| Bioventus LLC | $24.05 | 2023 | Durolane |
| Ferring Pharmaceuticals INC. | $21.36 | 2024 | Euflexxa |
| Smith+Nephew, INC. | $18.35 | 2025 | Pico 14, "Acticoat 4"" X 4""", Renasys Touch |
| Kci USA, INC. | $16.29 | 2023 | 3m Soluprep, Attest, 3m Medipore |
| Impactortho, INC. | $15.53 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perry Edinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.